Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News
  • Published:

Bills target biosimilar drugs

Nature volume 458, pages 394–395 (2009)Cite this article

House of Representatives divided over regulating generics.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Authors
  1. Meredith Wadman
    View author publications

    You can also search for this author in PubMed Google Scholar

Related links

Related links

Related links in Nature Research

Biotechnology@nature.com

Related external links

Eshoo bill (H.R. 1548)

Waxman bill (H.R. 1427)

Biotechnology Industry Organization's information on biosimilars

Generic Pharmaceuticals Association information on biosimilars

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wadman, M. Bills target biosimilar drugs. Nature 458, 394–395 (2009). https://doi.org/10.1038/458394b

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/458394b

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing